A
ATRO Medical B.V.
Health Tech & Medtech · Nijmegen, Netherlands · Founded 2016
ATRO Medical's Artimis Meniscus Prosthesis reduces pain and restores mobility for patients suffering from chronic pain after loss of their meniscus MoreLess
ATRO Medical is a Nijmegen (NL) based firm developing the orthopedic innovation of the decade: the first artificial meniscus. The Artimis® Meniscus Prosthesis is designed to restore the shock absorbing function in the knee joint. As such, it aims to relief pain for 100,000’s of patients who suffer after removal of the native meniscus. With Artimis® they regain quality of life. The surgery is minimally invasive, straight-forward and fast to perform. Our artificial meniscus has received FDA Breakthrough designation, got the prestigious EIC Accelerator grant and won the JNJ Quickfire Award as best innovation for veterans. The Artimis® is currently under clinical investigation in a European multi-center study. First results on pain relief at the 2-year endpoint are promising.
Keywords: Healthcare Innovation, Orthopedics, Knee surgery, Meniscus Implants, Meniscus Replacement, Sports Medicine, Medtech, FDA Breakthrough device, Polymer Implants
Talent graph
ATRO Medical B.V.'s talent
Source: Dealroom Talent Intelligence.
Investors
15 investors on ATRO Medical B.V.'s cap table
Sourced from Dealroom's funding and investor records.













Global footprint
Where ATRO Medical B.V. has talent and traffic
team presence
Market sentiment
What the market is saying about ATRO Medical B.V.
An AI-synthesized read of the highest-engagement posts about ATRO Medical B.V. on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See ATRO Medical B.V. on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.